ALRTF.US ALR Technologies Inc.
- Market cap
- USD 10.0M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is ALRTF.US undervalued?
Graham numberThe Graham number of ALR Technologies Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ALR Technologies Inc. fundamental analysis
No fundamental analysis for ALR Technologies Inc. yet.
ALR Technologies Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ALR Technologies Inc.
ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to add…
Full company profileALR Technologies Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ALR Technologies Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | 0.00 | 0.00 | 0.00 | 7.47K | 2.37K | 25.5K | 0.00 | 0.00 | - |
| Gross Profit | - | - | - | - | 0.00 | 4.95K | 1.19K | 3.44K | 0.00 | 0.00 | - |
| Operating Income | -1.03M | -1.07M | -2.18M | -3.74M | -3.83M | -2.94M | -4.27M | -4.81M | 3.41M | 2.88M | 3.49M |
| EBITDA | 27.00 | 86.3K | -2.18M | -3.74M | 26.0K | -33.6K | -592.00 | -140K | 84.00 | -2.32M | - |
| Net Income | -10.1M | -2.84M | -4.12M | -9.01M | -5.92M | -8.44M | -10.6M | -7.48M | -15.9M | -22.1M | -22.6M |
| EPS | -0.04 | -0.01 | -0.02 | -0.04 | -0.02 | -0.02 | -0.02 | -0.01 | -0.03 | -0.04 | -0.04 |
| Balance Sheet | |||||||||||
| Total Assets | 4.04K | 3.11K | 3.38K | 1.84K | 129K | 193K | 377K | 155K | 79.5K | 47.4K | 47.4K |
| Total Liabilities | 23.2M | 26.0M | 28.4M | 31.1M | 21.9M | 24.5M | 28.9M | 32.1M | 36.3M | 39.9M | 39.9M |
| Shareholders' Equity | -23.2M | -26.0M | -28.4M | -31.1M | -21.8M | -24.3M | -28.6M | -31.9M | -36.2M | -39.9M | -39.9M |
| Cash & Short-term Investments | 2.61K | 3.11K | 3.38K | 1.84K | 66.2K | 116K | 149K | 59.1K | 40.7K | 20.3K | 20.3K |
| Total Debt | 18.7M | 20.6M | 22.5M | 24.6M | 17.2M | 19.3M | 22.9M | 25.4M | 28.6M | 32.3M | 32.3M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.05M | -770K | -626K | -735K | -969K | -1.77M | -2.08M | -1.62M | -1.54M | -1.87M | -2.59M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -1.05M | -770K | -626K | -735K | -969K | -1.77M | -2.08M | -1.62M | -1.54M | -1.87M | -2.59M |
| Ratios | |||||||||||
| ROA | -250,099.1% | -91,353.3% | -122,028.8% | -489,963.9% | -4,591.4% | -4,369.7% | -2,814.6% | -4,816.4% | -19,979.4% | -46,561.0% | -47,652.8% |
| Net Profit Margin | - | - | - | - | - | -113,055.7% | -448,627.0% | -29,272.4% | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ALR Technologies Inc. dividends
ALR Technologies Inc. has not paid dividends in the last 9 fiscal years.
Who owns ALR Technologies Inc.
- Insiders 90.26%
- Institutions 0.00%
- Public & others 9.74%
- Shares outstanding 645M
- Free float 256M
ALR Technologies Inc. company profile
- Company name
- ALR Technologies Inc.
- Ticker
- ALRTF.US
- ISIN
- SGXZ33978792
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 7
- Fiscal year end
- December
- Address
- 9 Raffles Place, Singapore, Singapore, 048619
- Phone
- 65 3129 2924
- Website
- alrt.com
About ALR Technologies Inc.
ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of diabetes solution product for use by veterinarians in animal health. In addition, it offers healthcare services, including medical clinics, hospitals, and health plans, and veterinary clinics with diabetics being the initial patient targets. The company sells its products directly and through distributors in the United States, Brazil, the United Kingdom, European Union, and internationally. The company was incorporated in 1987 and is based in Singapore.
ALR Technologies Inc. management
6- Mr. Sidney S. ChanChairman, CEO, President, CFO, Chief Accounting Officer & Treasurer · born 1950
- Mr. Benjamin SzetoChief Legal Counsel, General Counsel & Secretary · born 1972
- Ms. Christine Y. S. KanVP of Corporate Development & Director · born 1953
- Mr. Steven Brassard C.A., CPADirector of Finance, Accounting & Administration · born 1986
- Ms. Jacqueline WuHead of Corporate Marketing
- Mr. Joe SternHead of Animal Health